Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Statistical properties of minimal sufficient balance and minimization as methods for controlling baseline covariate imbalance at the design stage of sequential clinical trials

  • Steven D. Lauzon*
  • , Viswanathan Ramakrishnan
  • , Paul J. Nietert
  • , Jody D. Ciolino
  • , Michael D. Hill
  • , Wenle Zhao
  • *Autor correspondiente de este trabajo
  • Medical University of South Carolina
  • Northwestern University
  • University of Calgary

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

8 Citas (Scopus)

Resumen

When the number of baseline covariates whose imbalance needs to be controlled in a sequential randomized controlled trial is large, minimization is the most commonly used method for randomizing treatment assignments. The lack of allocation randomness associated with the minimization method has been the source of controversy, and the need to reduce even minor imbalances inherent in the minimization method has been challenged. The minimal sufficient balance (MSB) method is an alternative to the minimization method. It prevents serious imbalance from a large number of covariates while maintaining a high level of allocation randomness. In this study, the two treatment allocation methods are compared with regards to the effectiveness of balancing covariates across treatment arms and allocation randomness in equal allocation clinical trials. The MSB method proves to be equal or superior in both respects. In addition, type I error rate is preserved in analyses for both balancing methods, when using a binary endpoint.

Idioma originalInglés
Páginas (desde-hasta)2506-2517
Número de páginas12
PublicaciónStatistics in Medicine
Volumen39
N.º19
DOI
EstadoPublicada - 30 ago. 2020
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Statistical properties of minimal sufficient balance and minimization as methods for controlling baseline covariate imbalance at the design stage of sequential clinical trials'. En conjunto forman una huella única.

Citar esto